Table:
begin	end	state
1	20	cytoplasmic
21	42	transmembrane
43	47	non-cytoplasmic
48	67	transmembrane
68	87	cytoplasmic
88	111	transmembrane
112	121	non-cytoplasmic
122	144	transmembrane
145	155	cytoplasmic
156	180	transmembrane
181	199	non-cytoplasmic
200	223	transmembrane
224	241	cytoplasmic
242	264	transmembrane
265	282	non-cytoplasmic
283	304	transmembrane
305	331	cytoplasmic
332	354	transmembrane
355	360	non-cytoplasmic
361	382	transmembrane
383	401	cytoplasmic
402	423	transmembrane
424	428	non-cytoplasmic
429	446	transmembrane
447	470	cytoplasmic

Input:
>WP_058929813.1 NCBI__GCF_001484605.1:WP_058929813.1
MEQQTMTSGRALGAALKPRQLTMMGLGSAIGAGLFIGSGAGIQAAGPAVLISYLVAGTLI
ILVMWALGEMAAANPDSGAFSVYTAKAYGPVAGATVGWLWWLQLVVVIAAEALGAAGLLS
TIFPALPVWLMAFVFIVVLTAVNLTSVKNFGEFEFWFALLKVAAIVGFLLVGAALLFGWL
PGVQSPGLANFTGDGFAPDGFAGIATALFVVAFAFGGTEIVSVAAAETAEPARSVRTAVR
TVLWRILVFYIGAIFVIAAVVPVGSAGLKSPFAAVLEAAGMPGAATAITLVAVAALLSAL
NANLYGASRMAYSLADRGEAPRLLASVSKARVPVVAVLASVAFGVVTVVLELAFPEKVLP
VLLNIVGSTCLLVWTSALLAQLALRLRANREGTELPLRMPGFPWLTCFGLLILAAIFTVG
FIGEDSRPQLLSTFALVALLAVANWLHHRSGKVAGRVEAAEGDKQPVLID

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server